The present study provides the first evidence that PKCδ regulates activity of eIF2α through induction of PKR, an eIF2α kinase, but not PERK and GCN2, leading to inhibition of translation initiation during terminal differentiation of APL and AML cells (Figure 12). The gene discussed is PRKCD; the disease is acute promyelocytic leukemia.